Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of lumiracoxib 400 mg in relieving moderate to
severe post-dental surgery pain, compared to both placebo and celecoxib 400 mg.